1.
International Journal of Pediatrics
;
(6): 128-132, 2020.
Article
in Chinese
| WPRIM
| ID: wpr-862938
ABSTRACT
Mycoplasma pneumoniae (MP) is one of the most important pathogens of communit acquired pneumonia (CAP).But the current treatment is unsatisfactory.The report of macrolide resistant isolates of mycoplasma pneumoniae pneumonia has increased worldwide.This paper reviews the current situation and the therapeutic advantages of integrated Chinese and Western medicine,and discusses the best approach to deal with this situation.